Monopar Therapeutics (MNPR) Selling, General & Administrative (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 1.32 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -37.00 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 2.17 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 493.70 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 647.70 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -1.52 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Monopar Therapeutics | 466.82 Mn | 466.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.58 Mn |
| Sep 30, 2024 | 590,624.00 |
| Jun 30, 2024 | 657,806.00 |
| Mar 31, 2024 | 757,281.00 |
| Sep 30, 2023 | 749,474.00 |
| Jun 30, 2023 | 733,496.00 |
| Mar 31, 2023 | 871,675.00 |
| Dec 31, 2022 | 806,030.00 |
| Sep 30, 2022 | 675,115.00 |
| Jun 30, 2022 | 684,877.00 |
| Mar 31, 2022 | 779,254.00 |
| Dec 31, 2021 | 698,441.00 |
| Sep 30, 2021 | 631,698.00 |
| Jun 30, 2021 | 615,965.00 |
| Mar 31, 2021 | 687,936.00 |
| Dec 31, 2020 | 628,377.00 |
| Sep 30, 2020 | 392,063.00 |
| Jun 30, 2020 | 631,629.00 |
| Mar 31, 2020 | 791,607.00 |
| Dec 31, 2019 | 641,117.00 |
| Sep 30, 2019 | 539,602.00 |
| Jun 30, 2019 | 602,815.00 |
| Mar 31, 2019 | 571,709.00 |
| Dec 31, 2018 | 405,376.00 |
| Sep 30, 2018 | 363,848.00 |
| Jun 30, 2018 | 363,848.00 |
| Mar 31, 2018 | 440,119.00 |
| Dec 31, 2017 | 427,485.00 |
| Sep 30, 2017 | 215,233.00 |
| Jun 30, 2017 | 283,364.00 |
| Mar 31, 2017 | 240,103.00 |